doc. MUDr. Daniela Žáčková, Ph.D.
Associate professor, Department of Internal Medicine, Hematology and Oncology
correspondence Address:
Jihlavská 340/20, 625 00 Brno
phone: | +420 532 23 2838, 3603 |
---|---|
e‑mail: |
social and academic networks: |
---|
Total number of publications: 222
2020
-
Výzvy na poli CML v roce 2020
Year: 2020, type: R&D Presentation
2019
-
DNA-based BCR-ABL1 analysis provides a „traffic light“ stratification model for chronic myeloid leukemia with implications for treatment free remission
Year: 2019, type: Conference abstract
-
Kde si dnes stojíme v léčbě CML
Year: 2019, type: R&D Presentation
-
Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin
American Journal of Hematology, year: 2019, volume: 94, edition: 11, DOI
-
The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview
Leukemia, year: 2019
-
Život s diagnózou: Chronická myeloidní leukemie
Year: 2019, type: R&D Presentation
2018
-
Analysis of serum lipids, cardiovascular risk and indication for statin therapy at the start and during imatinib and nilotinib therapy in de novo CML patients, results from real life prosective study
Year: 2018, type: Conference abstract
-
Analýza sérových lipidů, kardiovaskulárního rizika a indikace k hypolipidemické terapii u nemocných s de novo CML léčených imatinibem - výsledky z prospektivní studie
Year: 2018, type: Conference abstract
-
CML - Understanding your diagnosis
Year: 2018, type: R&D Presentation
-
Considerations for Treatment-free Remission in Patients With Chronic Myeloid Leukemia: A Joint Patient-Physician Perspective
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, year: 2018, volume: 18, edition: 6, DOI